drugs oseltamivir, zanamivir, amantadine and rimantadine are considered "Drug Category C" when used dur before pregnancy which means that there have been no clinical studies to evaluate its safety in pregnant women.
Due to the unknown effects of these drugs in pregnant women and their fetuses, only to be used during pregnancy if the potential benefit justifies the risk to the embryo or fetus. However, no adverse effects have been reported in women who received oseltamivir or zanamivir during pregnancy or their baby.
Venezuelan scientific Societies of Gynecology and Obstetrics and Infectious Diseases, recommends the use of oseltamivir as a drug of first choice for more experience in handling .
In the post partum period:
Under optimal care and personal protection, breastfeeding should be initiated immediately. If due to illness, the mother can not breastfeed safely, we recommend the removal of the milk, until they meet the following criteria:
1. Oseltamivir treatment for a minimum of 48 h.
2. Afebrile.
3. Management adequate respiratory secretions.
The visits should be absolutely restricted
The above recommendations on the treatment of influenza in pregnant women, were the result of work of the MPPS and several scientific societies, including RSCMV. ;
can access the Manual of Influenza, on our "Documents" "DOCUMENTS PHARMACEUTICAL ."
0 comments:
Post a Comment